These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 8814058)

  • 21. Fertility, ovarian failure, and pregnancy outcome in SLE patients treated with intravenous cyclophosphamide in Saudi Arabia.
    Alarfaj AS; Khalil N
    Clin Rheumatol; 2014 Dec; 33(12):1731-6. PubMed ID: 24894105
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis.
    Rathi M; Goyal A; Jaryal A; Sharma A; Gupta PK; Ramachandran R; Kumar V; Kohli HS; Sakhuja V; Jha V; Gupta KL
    Kidney Int; 2016 Jan; 89(1):235-42. PubMed ID: 26489028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of safety, efficacy and cost between oral pulse cyclophosphamide versus intravenous cyclophosphamide pulse therapy in severe systemic lupus erythematosus.
    Padiyar S; Arya S; Surin A; Viswanath V; Danda D
    Int J Rheum Dis; 2020 Jun; 23(6):800-804. PubMed ID: 32452167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome and prognostic indicators of diffuse proliferative lupus glomerulonephritis treated with sequential oral cyclophosphamide and azathioprine.
    Mok CC; Ho CT; Chan KW; Lau CS; Wong RW
    Arthritis Rheum; 2002 Apr; 46(4):1003-13. PubMed ID: 11953978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe infections in patients with autoimmune diseases treated with cyclophosphamide.
    Cavallasca JA; Costa CA; Maliandi Mdel R; Contini LE; Fernandez de Carrera E; Musuruana JL
    Reumatol Clin; 2015; 11(4):221-3. PubMed ID: 25455720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus.
    Vlachoyiannopoulos PG; Toya SP; Katsifis G; Zintzaras E; Tzioufas AG; Moutsopoulos HM
    J Rheumatol; 2008 Sep; 35(9):1768-75. PubMed ID: 18634157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infectious complications in SLE after immunosuppressive therapies.
    Kang I; Park SH
    Curr Opin Rheumatol; 2003 Sep; 15(5):528-34. PubMed ID: 12960476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic effect of cumulative corticosteroid dose and immunosuppressants on avascular necrosis in patients with systemic lupus erythematosus.
    Kwon HH; Bang SY; Won S; Park Y; Yi JH; Joo YB; Lee HS; Bae SC
    Lupus; 2018 Sep; 27(10):1644-1651. PubMed ID: 29950160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of short interval and low dose (SILD) with high dose of cyclophosphamide in the susceptibility to infection in SLE: a multicentrereal-world study.
    Shao M; Miao M; Zhang X; Zhang X; An Y; Guo H; Lei L; Zhao Q; Ding Y; Lin J; Wu R; Yu F; Li Y; Miao H; Zhang L; Du Y; Jiao R; Pang L; Long L; Yao X; Shi X; Wang F; Cui L; Zhang L; Liu S; Lu F; Luo K; Zhao S; Wang Y; Wu X; Wang Q; Liu H; Song S; Zhou X; Zhang X; Shi S; Zhu H; Chen Y; Yu H; Wu J; Yu R; Fan W; Liu S; Xu J; Chen Z; Shi L; He J; Zhang X; Li Z; Li R
    Lupus Sci Med; 2022 Nov; 9(1):. PubMed ID: 36351697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Corticosteroids and Cyclophosphamide on Sex Hormone Profiles in Male Patients With Systemic Lupus Erythematosus or Systemic Sclerosis.
    Arnaud L; Nordin A; Lundholm H; Svenungsson E; Hellbacher E; Wikner J; Zickert A; Gunnarsson I
    Arthritis Rheumatol; 2017 Jun; 69(6):1272-1279. PubMed ID: 28141919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) in systemic lupus erythematosus (SLE) with oral cyclophosphamide.
    Jasmin R; Sockalingam S; Shahrizaila N; Cheah TE; Zain AA; Goh KJ
    Lupus; 2012 Sep; 21(10):1119-23. PubMed ID: 22433918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus.
    Noël V; Lortholary O; Casassus P; Cohen P; Généreau T; André MH; Mouthon L; Guillevin L
    Ann Rheum Dis; 2001 Dec; 60(12):1141-4. PubMed ID: 11709457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for herpes zoster infection among Filipinos with systemic lupus erythematosus.
    Zamora LD; Collante MTM; Navarra SV
    Int J Rheum Dis; 2020 Feb; 23(2):197-202. PubMed ID: 31692250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Infection and systemic lupus erythematosus: analysis of a series of 145 patients].
    Formiga Pérez F; Moga Sampere I; Canet González R; Pac Ferraz M; Mitjavila Villero F; Fernández Nogués F
    Rev Clin Esp; 1993 Jul; 193(3):105-9. PubMed ID: 8356286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic lupus erythematosus and infections.
    Singh BK; Singh S
    Reumatismo; 2020 Nov; 72(3):154-169. PubMed ID: 33213128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of a gonadotropin-releasing hormone analog for ovarian function preservation after intravenous cyclophosphamide therapy in systemic lupus erythematosus patients: a retrospective inception cohort study.
    Koga T; Umeda M; Endo Y; Ishida M; Fujita Y; Tsuji S; Takatani A; Shimizu T; Sumiyoshi R; Igawa T; Fukui S; Nishino A; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Murakami N; Kitajima M; Kawakami A
    Int J Rheum Dis; 2018 Jun; 21(6):1287-1292. PubMed ID: 29879312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus.
    Petri M; Jones RJ; Brodsky RA
    Arthritis Rheum; 2003 Jan; 48(1):166-73. PubMed ID: 12528116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relative risk and attributable risk needed to interpret "factors predictive of infection in cyclophosphamide-treated lupus patients": comment on the article by Pryor et al.
    Alarcón GS
    Arthritis Rheum; 1997 Jun; 40(6):1186. PubMed ID: 9182938
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevalence of premature ovarian failure in systemic lupus erythematosus patients treated with immunosuppressive agents in Thailand.
    Akawatcharangura P; Taechakraichana N; Osiri M
    Lupus; 2016 Apr; 25(4):436-44. PubMed ID: 26621134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of myelotoxicity with intravenous cyclophosphamide in patients with systemic lupus erythematosus.
    Katsifis GE; Tzioufas AG; Vlachoyiannopoulos PG; Voulgarelis M; Moutsopoulos HM; Ioannidis JP
    Rheumatology (Oxford); 2002 Jul; 41(7):780-6. PubMed ID: 12096228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.